E. M. Rustoy et al. / Tetrahedron: Asymmetry 15 (2004) 3763–3768
3767
25
tR (S) = 9.6min). ½a ¼ ꢀ4:1 (c = 0.45, MeOH)
pension was shaken (200rpm) at 30ꢁC and the progress
of the reaction monitored by GLC. When the acid was
converted into the alkyl ester, the enzyme was filtered
off and the solvent evaporated. Products 2a–e were iden-
D
25
D
{lit.11 ½a ¼ ꢀ4:9 (c = 0.47, EtOH)}.
4.4.1.3. (S)-Di-n-propyl-2-hydroxyglutarate 4c. 100%
Conversion; (S): 94% ee; tR = 13.8min (tR (R) =
1
tified by GC–MS and by H and 13C NMR spectro-
25
D
scopy. Tests with other lipases were performed under
13.3min; tR (S) = 13.7min). ½a ¼ ꢀ6:9 (c =
1
the same experimental conditions. IR, H NMR, 13C
25
0.24, MeOH) {lit.11 ½a ¼ ꢀ5:5 (c = 0.11, MeOH)}.
D
NMR and MS data of compounds 2a–e were in accord-
ance with those reported in the literature.11,21,22 Yields
of compounds 2a–e are reported in Table 2.
4.4.1.4. (S)-Di-i-propyl-2-hydroxyglutarate 4d. 98%
Conversion; (S): 99% ee; tR = 11,9min (tR (R) =
25
D
11.3min; tR (S) = 11.9min). ½a ¼ ꢀ3:5 (c =
25
0.88, MeOH) {lit.11 ½a ¼ ꢀ1:1 (c = 1.4, MeOH)}.
4.2.2. Di-i-butyl-2-oxoglutarate 2f. 100% Yield. IR
D
1
(film) cmꢀ1: 1780 (C@O), COO–(1) and (5): 1730. H
NMR (CDCl3)
d (ppm): 0.93 (d, 6H, (CH3)2-
4.4.1.5. (S)-Di-n-butyl-2-hydroxyglutarate 4e. 40%
Conversion; (S): 93% ee; tR = 15.2min (tR (R) =
CHCH2OOCCH2–)), 0.98 (d, 6H, (CH3)2CHCH2OO-
COC–)), 1.95 (m, 1H, (CH3)2CHCH2OOCCH2–)), 2.05
(m, 1H, (CH3)2CHCH2OOCOC–)), 2.70 (t, 2H, (CH3)2-
CHCH2OOCCH2–)), 3.18 (t, 2H, (CH3)2CHCH2OO-
COCCH2–)), 3.89 (d, 2H, (CH3)2CHCH2OOCCH2–)),
4.12 (d, 2H, (CH3)2CHCH2OOCOC–)). 13C NMR
(CDCl3): 18.96 (C30-C40), 27.61 (C-3), 34.27 (C-4),
70.85 (C-20), 72.43 (C-10), 160.56 (C-1), 161.95 (C-5),
192.54(C-2). EI-MS ( m/z,%): 258 (1), 183 (13), 101
(11), 57 (100), 41 (56). HR-MS: 258.3165 (C13H23Oþ5 ;
calc. 258.3172).
25
D
14.7min; tR (S) = 15.1min). ½a ¼ ꢀ4:6 (c = 0.76,
25
MeOH) {lit.11 (R) ½a ¼ þ2:2 (c = 0.76, MeOH)}.
D
4.4.1.6.
Di-i-butyl-2-hydroxyglutarate
4f. 26%
Conversion.; (S): 95% ee; tR = 14.7min; tR (R) =
14.3min; tR (S) = 14.7min; IR (film) cmꢀ1: 34 55
(OH), 1735 (COO); H NMR (CDCl3) d (ppm): 0.92
1
(d, 6H, (CH3)2CHCH2OOCCH2–)), 0.94(dd, 6H,
(CH3)2CHCH2OOC(OH)HC–)), 1.95 (m, 1H, (CH3)2-
CHCH2OOCCH2–)), 1.81–1.99 (m, 1H, –CH2CH2CH-
OHCOO–)), 2.05 (m, 1H, (CH3)2CHCH2OOCOC)),
2.38–2.53 (dd, 2H, –CH2CH2CHOHCOO–)), 3.87 (d,
2H, (CH3)2CHCH2OOCCH2–)), 3.97 (dd, 2H, ((CH3)2-
CHCH2OOC(OH)HC–)), 4.23 (m, 1H(CH3)2CH-
CH2OOC(OH)HC–)). 13C NMR (CDCl3): 18.96
(–COOCH(CH3)2), 18.91 (–CHOHCOOCH(CH3)2), 27.7
(–COOCHCH2(CH3)2), 29.81 (–CH2CHOHCOO–),
29.55 (–OCOCH2CH2CHOHCOO–), 69.55 (–CH2CO-
OCHCH2(CH3)2), 70.56 (–CHOHCOOCHCH2(CH3)2),
71.89 (–CHOH–), 173.18 (–CHOHCO–), 174.79
(–CH2CO–). EI-MS (m/z, %): 259 (1), 245 (4), 187
4.3. Di-alkyl-2-oxoglutarate microbial reduction
Fresh cultures and freeze-dried yeast cells of M. rouxii
were grown as described previously.13 Biomass (2g)
obtained from cultures was incubated with 5ml of
organic solvents such as ethyl acetate, toluene, hexane,
etc, alone or in biphasic systems mixed with 2ml sterile
water, in 25ml sterile Erlenmeyer flasks stoppered and
sealed. Water incubations were performed in 5ml sterile
water alone. The substrates were added to these systems
(0.1–0.25mmol for standard assays) and incubated at
28ꢁC in a rotatory shaker at 200 rpm. for different times.
The reactions were stopped by centrifugation at
10,000 · g; the supernatants were removed and, when
applied, water phases were extracted with ethyl acetate.
The products were purified by flash chromatography
(eluant: hexane:ethyl acetate, 95:5 to 75:25). All experi-
ments were performed in duplicate.
(41), 103 (59), 59 (100). HR-MS: 260.3328 (C13H24Oþ5 ;
25
D
calcd 260.3332) 91% ee; tR = 14.5min; ½a ¼ ꢀ5:2 (c =
0.68, MeOH).
4.4.1.7. Reduction of ethyl 2-oxo-4-phenylbutanoate
2g. 96% Yield; IR (film) cmꢀ1: 3400 (OH), 1724
(COO); 1H NMR (CDCl3) d (ppm) = 7.35–7.10 (m,
5H, aromatic H), 4.20 (q, 2H, –COOCH2CH3), 4.17
(m, 1H, –CHOH–), 2.93 (br s, 1H, OH), 2.77 (t, 2H,
4.4. Reduction products
PhCH2CH2CHOHCOO–),
2.17–1.89
(m,
2H,
1
IR, H NMR, 13C NMR and MS data of compounds
PhCH2CH2CHOHCOO–), 1.28 (t, 3H, COOCH2CH3).
13C NMR (CDCl3) d (ppm) = 175.79 (CO), 142.29,
128.74, 128.01, 125.47 (aromatic C), 69.47 (–CHOH–),
60.91 (–COOCH2CH3), 34.78 (–CH2CH2CHOHCOO–),
32.56 (–CH2CH2CHOHCOO–), 14.01 (–COOCH2CH3).
4a–e and 3a and 3b are in accordance with those re-
ported in literature.11,23,24 Conversion of compounds
4a–e obtained by M. rouxii yeast-like cells reduction
are reported in Table 2 and of 3a and 3b and 4c–f ob-
tained by M. rouxii freeze-dried yeast-like cells reduc-
tion in Table 3.
EI-MS (m/z, %): 208 (4), 190 (6), 163 (49), 145 (69),
20
D
91 (100). ½a ¼ þ19:4 (c = 1.1, CHCl3) {lit.25 (R):
24
½a ¼ ꢀ21:6
(c = 1.1,
CHCl3)}.
Ee = 91%,
D
tR = 15.9min.
4.4.1. M. rouxii yeast cells reduction
4.4.1.1. (S)-Di-methyl-2-hydroxyglutarate 4a. 100%
Conversion; (S): 95% ee; tR = 8.9min (tR (R) = 8.5min;
4.4.2. M. rouxii freeze-dried yeast cells reduc-
tion. Reduction reactions were performed under the
conditions previously described with fresh cells.
Freeze-dried biomass (0.5g) were resuspended in 1ml
sterile water, previous to the addition of the organic
solvents.
25
D
tR (S) = 8.9min). ½a ¼ ꢀ5:2 (c = 0.38, MeOH) {lit.11
25
½a ¼ ꢀ4:5 (c = 0.22, MeOH)}.
D
4.4.1.2. (S)-Di-ethyl-2-hydroxyglutarate 4b. 100%
Conversion; (S): 98% ee; tR = 9.6min (tR (R) = 9.3min;